Updated:
North American Science Associates
North American Science Associates (NAMSA) is a contract research organization (CRO) and consulting firm headquartered in Northwood, Ohio. It was founded to...
North American Science Associates
North American Science Associates (NAMSA) is a contract research organization (CRO) and consulting firm headquartered in Northwood, Ohio. It was founded to assist medical device and pharmaceutical companies with regulatory strategy, preclinical and clinical testing, and quality assurance. The firm's activities are oriented toward product development support, not capital management. NAMSA's services include biocompatibility testing, sterilization validation, clinical trial management, and regulatory submissions for markets such as the U.S. and Europe. The firm does not operate an investment portfolio or deploy capital in companies; instead, it derives revenue from client contracts for testing and consulting engagements. The firm's team includes regulatory scientists, toxicologists, and clinical operations staff, but no recent AUM or professional count has been publicly disclosed by the firm. No additional offices or affiliated investment vehicles have been identified. NAMSA's structural differentiator is its purely service-based model, providing outsourced regulatory expertise rather than managing third-party capital. This positions it distinctly from family offices or asset managers.
General information
Firm type
other
Location
Region
North America
Country
United States
City
Northwood
Corporate office
Northwood, OH, United States
Frequently asked questions
What services does North American Science Associates provide?
NAMSA provides biocompatibility testing, sterilization validation, analytical chemistry, clinical trial management, and regulatory submission support for medical devices and pharmaceutical products (per the firm's website).
Does North American Science Associates invest in companies or funds?
No. NAMSA is a service provider, not an investment firm. It does not deploy capital into portfolio companies, funds, or direct investments.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: